 ABINGDON, OXFORDSHIRE ACCESSWIRE March 2, 2020 Midatech Pharma PLC AIM:MTPH.L; NASDAQ:MTP Midatech or the Company, an RD; biotechnology company focused on delivering innovative oncology and rare disease products to patients, announces that all resolutions were passed at a general meeting of shareholders of the Company held earlier today. Consequently, with effect from tomorrow, 3 March 2020, Midatechs existing ordinary shares of 0.005p each in the capital of the Company Existing Ordinary Shares will be consolidated on a one for 20 basis into new ordinary shares of 0.1p each in the capital of the Company New Ordinary Shares. 